期刊文献+

FGF-21、血脂代谢、hsCRP及脐血流在预测子痫前期中的意义 被引量:1

The significance of FGF-21,blood lipid metabolism,hsCRP and umbilical blood flow in the prediction of preeclampsia
下载PDF
导出
摘要 目的了解血成纤维细胞生长因子-21(FGF-21)、血脂代谢、超敏C反应蛋白(hs CRP)及脐血流在预测子痫前期中的意义。方法选择单胎子痫前期孕妇89例为研究组,同期正常妊娠的孕妇83例为对照组,在生化分析仪上测定血清总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白(HDLC)、低密度脂蛋白(LDLC)水平;ELISA法测定研究组和对照组中孕妇血FGF-21水平;免疫透射比浊法测定孕妇血hs CRP的质量浓度;三维彩色多普勒诊断仪检测脐动脉血流S/D值。结果与对照组比较,研究组的TC、LDLC、FGF-21、hs CRP水平及脐动脉血流S/D值明显升高,而HDLC水平则降低,差异均有统计学意义(P<0.01)。子痫前期FGF-21水平与TC、TG、LDLC呈正相关(P<0.05),与HDLC负相关,而与hs CRP及脐动脉血流S/D值无相关性(P>0.05)。结论血FGF-21水平的升高可能是子痫前期的一个独立危险因素,对预测子痫前期的发生有一定的意义。 Objective To investigate the significance of FGF-21,blood lipid metabolism,hs CRP and umbilical blood flow in the prediction of preeclampsia. Methods 89 cases of pregnant women with single fetus in preeclampsia were selected as Study Group,and 83 cases of healthy pregnant women at the same period were selected as control group; Total cholesterol(TC),triglyceride(TG),high density lipoprotein(HDLC) and low density lipoprotein(LDLC) were measured by biochemical analyzer; FGF-21 was measured by enzyme-linked immunoassay(ELISA); hs CRP was measured by Immune transmission turbidity; and the umbilical artery blood S/D was determined by 3D-color Doppler echocardiography. Results Compared with Control Group,Study Group had a significantly higher TC,HDLC,LDLC,umbilical artery blood S/D(P〈0.05),but had a decreased level of HDLC,and the difference was statistically significant(P〈0.01). Serum level of FGF-21 in preeclampsia was positively correlated to TC,TG and LDLC(P〈0.05),but have no correlation to umbilical artery blood S/D(P〈0.05). Conclusion Increased serum level of FGF-21 may be an independent factor for preeclampsia,which may be of significance for early detection of preeclampsia.
出处 《广东医学院学报》 2015年第6期664-666,共3页 Journal of Guangdong Medical College
基金 广东省湛江市2013年非资助科技攻关计划项目(No.2013B01122)
关键词 FGF-21 子痫前期 血脂代谢 HSCRP FGF-21 preeclampsia blood lipid metabolism hsCRP
  • 相关文献

参考文献10

  • 1张为远.规范妊娠期高血压疾病的诊疗与管理[J].中华妇产科杂志,2012,47(6):401-404. 被引量:33
  • 2Li H, Zhang J, Jia W. Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology[J]. Front Med, 2013, 7(1) : 25-30.
  • 3沈虹,程蔚蔚.正常和病理妊娠时血脂、脂蛋白酯酶和内皮酯酶变化情况的研究[J].实用妇产科杂志,2013,29(2):99-102. 被引量:8
  • 4Yasojima K, Schwab C, Mc Geer E G, et al. Generation of C reactive protein and complement components in athero- sclerotic plaques[J]. Am J Pathol, 2001, 158(3): 1039-1051.
  • 5Guiot C, Gaglioti P, Oberto M, et al. Is three-dimensional power doppler ultrasound useful in the assessment of placen- tal perfusion in normal and growth-restricted pregnancies[J]. Ultrasound Obstet Gynecol, 2008, 31 (5): 171-176.
  • 6Prout A P, Frasch M G, Veldhuizen R, et al.The impact of intermittent umbilical cord occlusions on the inflammatory response in preterm fetal sheep[J]. PLoS One, 2012, 7(6): e39043.
  • 7Prout A P, Frasch M G, Veldhuizen R A W, et al. Systemic and cerebral inflammatory response to umbilical cord occlu- sions with worsening acidosis in the ovine fetus[J]. Am J Obstet Gynecol, 2010, 202(1): 82.
  • 8Fukumoto S. Actions and mode of actions of FGF19 sub- family members[J]. Endocr J, 2008, 55(1): 23-31.
  • 9Stepan H, Kley K, Hindricks J, et al. Serum levels of the adipokine fibroblast growth factor-21 are increased in pre- eclampsia[J]. Cytokine, 2013, 62(2): 322-326.
  • 10陈朝霞,王祥珍.妊娠高血压疾病患者免疫功能和C-反应蛋白水平变化及其临床意义[J].广东医学院学报,2011,29(3):263-265. 被引量:8

二级参考文献39

  • 1赵建珍.妊高征患者C-反应蛋白的表达及其意义[J].生殖与避孕,2005,25(4):220-222. 被引量:2
  • 2Garcia R G, Celedon J, Sierra-Laguado J, et al. Raised Creactive protein and impaired flow-mediated vasodilation precede the development ofpreeclampsia[J]. Am J Hypertens, 2007, 20(1):98-103.
  • 3Gu H, Zhang S, Qiao Y, et al. A study of maternal hemody- namic change during healthy pregnancy and women with gestation hypertension[J]. J Biomed Mater Eng, 2006, 16(1): 77-82.
  • 4Du Clos T W. Function of C-reactive protein[J]. J Ann Med, 2000, 32(4):274-278.
  • 5Ferranti S D, Rifai N.C-reactive protein and cardiovascular disease: a review of risk prediction and interventions[J]. J Clin Chim Acta, 2002, 317(1-2): 1-15.
  • 6Graham T E, Yang Q, Bliiher M, et al. Retinol-binding protein 4 and insulin resistance in lean and obese subjects and subjects with type2 diabetes[J]. N Engl J Med, 2006, 354 (24):2552-2563.
  • 7Lowe SA, Brown MA, Dekker GA, et al. Guidelines for the management of hypertensive disorders of pregnancy. Aust N Z J Obstet Gynaecol, 2009, 49:242-246.
  • 8Repoa of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am JObstet Gynecol, 2000, 183:S1-S22.
  • 9Ascarelli MH, Johnson V, McCreary H, et al. Postpartum preeclampsia management with furosemide : a randomized clinical trial. Obstet Gynecol, 2005, 105:29-33.
  • 10张为远.中华围产医学.北京:人民卫生出版社,2012:1431-1434.

共引文献46

同被引文献4

引证文献1

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部